| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911624 | Lung Cancer | 2005 | 12 Pages |
Abstract
The pemetrexed-vinorelbine combination is well tolerated and shows activity as first-line treatment in advanced NSCLC patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Stephen J. Clarke, Michael J. Boyer, Michael Millward, Craig Underhill, Eugene Moylan, Desmond Yip, Shane White, Annabel Childs, Phillip Beale, Jane Latz, Ajit Suri, Jose L. Iglesias,